SCHEMBL4772795

SCHEMBL4772795

CCC(N)c1ncccc1[N+](=O)[O-]

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.54
PDE10A Q9Y233 1/20 0.45
POLB P06746 1/20 0.44
NPC1 O15118 3/20 0.42
MAPT P10636 4/20 0.42
MAPK1 P28482 2/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
MEN1 O00255 4/20 0.41
KMT2A Q03164 4/20 0.41
LMNA P02545 1/20 0.41
PAX8 Q06710 1/20 0.41
CYP1A2 P05177 2/20 0.41
NCOA1 Q15788 1/20 0.41
NCOA3 Q9Y6Q9 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
PKM P14618 1/20 0.40
RAB9A P51151 3/20 0.40
TSHR P16473 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29577152 0.86 ALDH1A1 (0.51) ALDH1A1PDE10APOLBNPC1MAPT
SCHEMBL16443935 0.84 ALDH1A1 (0.50) ALDH1A1PDE10APOLBNPC1MAPT
SCHEMBL17806132 0.83 ALDH1A1 (0.58) ALDH1A1PDE10APOLBNPC1MAPT
SCHEMBL31392522 0.82 ALDH1A1 (0.57) ALDH1A1PDE10APOLBNPC1MAPT
SCHEMBL1332901 0.81 ALDH1A1 (0.54) ALDH1A1PDE10APOLBNPC1MAPT
Ammonia Solution, Strong SCHEMBL4275842 0.81 ALDH1A1 (0.56) ALDH1A1PDE10APOLBNPC1MAPT
SCHEMBL2742977 0.80 ALDH1A1 (0.62) ALDH1A1PDE10APOLBNPC1MAPT
SCHEMBL1268308 0.78 ALDH1A1 (0.57) ALDH1A1PDE10APOLBNPC1MAPT
SCHEMBL1268313 0.78 ALDH1A1 (0.57) ALDH1A1PDE10APOLBNPC1MAPT
SCHEMBL3800934 0.75 ALDH1A1 (0.56) ALDH1A1PDE10APOLBNPC1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1322309-B1 HIGH AFFINITY SMALL MOLECULE C5A RECEPTOR MODULATORS NEUROGEN CORP (US) 2008-08-13 EP disclosed
US-7271270-B2 High affinity small molecule C5a receptor modulators NEUROGEN CORPORATION (US) 2007-09-18 US disclosed
US-20070027158-A1 High affinity small molecule C5a receptor modulators NEUROGEN CORPORATION 2007-02-01 US disclosed
US-6884815-B1 High affinity small molecule C5a receptor modulators NEUROGEN CORPORATION (US) 2005-04-26 US disclosed
EP-1322309-A4 HIGH AFFINITY SMALL MOLECULE C5A RECEPTOR MODULATORS NEUROGEN CORP (US) 2004-10-13 EP disclosed
US-6723743-B1 TREATING PATIENT SUFFERING FROM RHEUMATOID ARTHRITIS, PSORIASIS, BRONCHIAL ASTHMA, ALZHEIMER'S DISEASE, MYOCARDIAL INFARCTION OR ATHEROSCLEROSIS NEUROGEN CORPORATION 2004-04-20 US disclosed
EP-1322309-A2 HIGH AFFINITY SMALL MOLECULE C5A RECEPTOR MODULATORS Neurogen Corporation (US) 2003-07-02 EP disclosed
WO-2002049993-A2 HIGH AFFINITY SMALL MOLECULE C5A RECEPTOR MODULATORS NEUROGEN CORPORATION (US) 2002-06-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070027158-A1 High affinity small molecule C5a receptor modulators C3AR1, C5AR1, C5AR2 ALDH1A1 4042/4885PDE10A 2159/4885POLB 3875/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.